These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Marin M, Broder KR, Temte JL, Snider DE, Seward JF, Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep; 2010 May 07; 59(RR-3):1-12. PubMed ID: 20448530 [Abstract] [Full Text] [Related]
9. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age. Goh P, Lim FS, Han HH, Willems P. Infection; 2007 Oct 07; 35(5):326-33. PubMed ID: 17710370 [Abstract] [Full Text] [Related]
10. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine. Vesikari T, Sadzot-Delvaux C, Rentier B, Gershon A. Pediatr Infect Dis J; 2007 Jul 07; 26(7):632-8. PubMed ID: 17596807 [Abstract] [Full Text] [Related]
17. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination. Jean-Jasmin LM, Lynette SP, Stefan M, Kai CS, Chew FT, Wah LB. Southeast Asian J Trop Med Public Health; 2004 Sep 04; 35(3):693-6. PubMed ID: 15689089 [Abstract] [Full Text] [Related]
20. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella. Ramet J. Int J Infect Dis; 2007 Nov 04; 11 Suppl 2():S49-55. PubMed ID: 18162247 [Abstract] [Full Text] [Related] Page: [Next] [New Search]